[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"stress-incontinence-female\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:stress-incontinence-female":120},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,49,77,106],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100544518","tens-analgesia-during-outpatient-urethral-bulking-for-stress-urinary-incontinence-100544518",false,"NCT06369922","TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.","Transcutaneous Electrical Nerve Stimulation Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.","TENSUB","Inclusion Criteria:\n\n* • Women, Age ≥18 years\n\n  * Diagnosis of SUI\n  * Scheduled to undergo transurethral bulking in the office\n  * Able to read\u002Fwrite English\n\nExclusion Criteria:\n\n* • Cutaneous damage such as ulcers or broken skin on target treatment area\n\n  * Currently implanted cardiac pacemaker or defibrillator\n  * Pre-procedural use of opioids for pain management, less than 8 hours from last dose\n  * Participants with altered sensation below the umbilicus","FEMALE","18 Years",{"count":20,"type":21},100,"ESTIMATED","INTERVENTIONAL",[24],"NA","This will be a double-blind randomized control trial in women with stress urinary incontinence who are undergoing an outpatient transurethral bulking procedure for stress urinary incontinence. Subjects will be identified by the University of Rochester urologists and urogynecologists participating in the study who currently oversee stress incontinence care. Subjects will be randomized into two groups. One group will be undergoing the cystoscopy with transcutaneous electrical nerve stimulation (TENS) for analgesia, and the second group will have the cystoscopy with placebo TENS.",[27,28,29,30,31],"Stress Incontinence Female","Urinary Incontinence","Urinary Incontinence,Stress","Pain","Pain Acute",[33,34,35],"TENS","pain","Transcutaneous Electrical Nerve Stimulation Analgesia","RECRUITING","2026-05-11",{"date":39,"type":40},"2026-05-13","ACTUAL",{"date":42,"type":40},"2024-07-01",{"date":44,"type":21},"2027-06-01",{"name":46,"class":47},"University of Rochester","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":4,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":22,"phases":59,"briefSummary":60,"conditions":61,"keywords":64,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":48},"100634622","impact-of-cmg-vs-vcmg-in-recurrent-stress-incontinence--a-pilot-study-100634622","NCT07542080","Impact of CMG vs VCMG in Recurrent Stress Incontinence- A Pilot Study","Impact of Urodynamic and Video-urodynamic Testing on Surgical Outcomes in Women With Recurrent Urinary Incontinence","Inclusion Criteria:\n\n* competent (able to consent)\n* adult women (over 18 years old)\n* with recurrent stress urinary incontinence\n\nExclusion Criteria:\n\n* women who are pregnant\n* unfit for surgery\n* body mass index (BMI) over 35\n* background of pelvic radiotherapy or relevant neurogenic disease that would put them at risk of neurogenic bladder","100 Years",{"count":58,"type":21},30,[24],"To asses feasibility of a prospective randomised trial comparing the outcomes of surgery for recurrent urinary incontinence after video-urodynamic(VCMG)and urodynamic(UDS)investigations. One of the greatest challenges for clinicians is the lack of correlation between bothersome urinary symptoms and the underlying urinary tract dysfunction. This has led to the development of several investigations aimed at improving diagnostic accuracy, with UDS and VUDS being the most noteworthy. Despite the heavy reliance on these invasive tests by clinicians, their indications and efficacy remain controversial and supporting literature data is scarce and nonvalidated. The investigators will perform a prospective randomised study of 30 women referred to our tertiary urological services at University College London Hospitals (UCLH) for treatment of recurrent stress urinary incontinence. The women will be investigated with either UDS or VUDS prior to receiving medical and surgical treatment tailored to the identified underlying urinary tract dysfunction. Adult women with symptoms suggestive of recurrent stress urinary incontinence after failed continence surgery will be included. Women who are pregnant, unfit for surgery, have a background of pelvic radiotherapy or relevant neurogenic disease that would put them at risk of neurogenic bladder will be excluded. UDS\u002FVUDS will be performed under the care of Functional, Reconstructive and Adolescent Urology (FFA) Urology Service at UCLH adhering to standardised protocols. Treatment will be provided by FRA Team at UCLH. The primary outcome is assessment of symptoms of urinary incontinence by using validated questionnaires. Results will be correlated with patient characteristics, X-ray exposure, patient experience metrics, outcome and expenses to determine in which sub-populations performing UDS or VUDS has a higher impact on outcomes and when they should be avoided.",[27,62,63],"Urodynamic Exam","Urodynamic Stress Incontinence",[65,66,67],"urodynamics","videourodynamics","stress incontinence","2026-04-28",{"date":70,"type":40},"2026-05-05",{"date":72,"type":40},"2025-10-06",{"date":74,"type":21},"2027-06-06",{"name":76,"class":47},"University College, London",{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":81,"acronym":4,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":83,"targetDuration":4,"studyType":22,"phases":85,"briefSummary":86,"conditions":87,"keywords":89,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":105},"100593627","sequence-of-midurethral-sling-placement-during-robotic-sacrocolpopexy-100593627","NCT07008898","Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy","Inclusion Criteria:\n\n* At least 18 years of age\n* Able to speak and read English and Spanish\n\n  * Diagnosis of pelvic organ prolapse stage 2-4\n  * Planning to undergo a robotic-assisted sacrocolpopexy\n  * Demonstrable SUI (either by CST, with or without prolapse reduction, or UDS) within the year prior to enrollment\n  * Planning to undergo concomitant SUI correction with MUS at the time of RSC\n\nExclusion Criteria:\n\n* Less than 18 years of age\n* Unable to speak and read English or Spanish\n* No diagnosis of SUI (prophylactic slings)\n* History of prior surgery for SUI\n* Bladder capacity \\\u003C200 mL or post-void residual (PVR) \\>150 mL\n* Current genitourinary fistula or urethral diverticulum",{"count":84,"type":21},110,[24],"This study looks at the best time to place a midurethral sling (MUS), which is a small piece of mesh used to treat stress urinary incontinence (SUI) (leaking urine when you cough, laugh, or exercise). The sling is placed during a type of surgery called robotic sacrocolpopexy (RSC). This surgery helps fix pelvic organ prolapse, when organs like the bladder or uterus drop from their normal place.\n\nDoctors can place the sling either before or after they lift and support the top of the vagina during surgery, but they aren't sure which timing works better. In this study, investigators are comparing what is the best time to place the sling, how the patient feels after surgery and if a patient's symptoms got better or worse.",[27,88],"Pelvic Organ Prolapse",[90,91,92,93,94,95],"Stress incontinence","Pelvic organ prolapse","Midurethral sling","Sucess rates","Complication rates","Patient satisfaction","2026-02-12",{"date":98,"type":40},"2026-02-17",{"date":100,"type":40},"2025-07-08",{"date":102,"type":21},"2027-06",{"name":104,"class":47},"University of Alabama at Birmingham",2,{"id":107,"slug":108,"hasResults":11,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":4,"eligibilityCriteria":112,"healthyVolunteers":11,"sex":17,"minAge":113,"maxAge":114,"enrollmentInfo":115,"targetDuration":4,"studyType":22,"phases":117,"briefSummary":118,"conditions":119,"keywords":4,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":122,"startDateStruct":124,"completionDateStruct":126,"leadSponsor":128,"locationsCount":48},"100584140","prp--pdo-threads-in-treatment-of-stress-incontinence-100584140","NCT06885463","PRP & PDO Threads in Treatment of Stress Incontinence","The Role of Platelets Rich Plasma Combined With PDO Threads in Treatment of Stress Incontinence in Egyptian Women","Inclusion Criteria:\n\n* Nonpregnant Women with SUI\n* Age between 20 to 45 years\n* Patients had a history of failed conservative treatment\n* Patients were on the waiting list for surgical treatment of SUI\n\nExclusion Criteria:\n\n* Under anti-platelet agent treatment\n* Under NSAIDs\n* Platelet dysfunction syndrome\n* Critical thrombocytopenia\n* Hypofibrionogenaemia\n* Sepsis\n* Acute and chronic infections\n* Chronic liver disease\n* Anti-coagulation therapy\n* History of malignancy\n* Pregnancy\n* history of active malignant pathology\n* mental disorders making them unable to give consent\n* genitourinary fistula\n* pelvic organs prolapse stage \\>2 according to the Pelvic Organ Prolapse Quantification system, and detrusor overactivity on urodynamics.","20 Years","45 Years",{"count":116,"type":21},10,[24],"The study will include 10 women with pure or predominant SUI symptoms, with severe urodynamic stress incontinence on urodynamics defined as loss of urine with sudden increases in abdominal pressure: eg, coughing, sneezing, or laughing). This will be conducted at the Department of Obstetrics and Gynecology, Faculty of Medicine, Al-Azhar University. The purpose of study is to evaluate the efficacy and safety of platelets rich plasma combined with PDO threads in the treatment of stress incontinence in Egyptian women.",[120],"Stress Incontinence, Female","2025-03-18",{"date":123,"type":40},"2025-03-20",{"date":125,"type":40},"2025-03-01",{"date":127,"type":21},"2025-06-30",{"name":129,"class":47},"Al-Azhar University"]